The 20 Best Diabetic Neuropathy Doctors Near Me in Ypsilanti, MI

Dr. Feldman is the director of the NeuroNetwork for Emerging Therapies at Michigan Medicine and the ALS Center of Excellence at Michigan Medicine. The latter includes the Pranger ALS Clinic, one of the top multidisciplinary clinics caring for those suffering from amyotrophic lateral sclerosis (ALS). She serves as the University of Michigan James W. Albers Distinguished University Professor and the Russell N. DeJong Professor of Neurology at Michigan Medicine. Dr. Feldman is one of the world’s leading authorities on neurodegenerative disease.Dr. Feldman is a compassionate and dedicated physician who cares deeply about her patients. She has been recognized for her clinical excellence by numerous organizations and is annually named as one of the “Best Doctors in America.” Her forward-thinking, collaborative, multidisciplinary approach has transformed how neurodegenerative diseases are diagnosed, treated, and prevented.Dr. Feldman has made significant contributions to biomedical research and clinical care in many critical areas of neurodegenerative disease. She has authored over 530 peer-reviewed publications, 74 book chapters, and 5 books on the pathology, diagnosis, and treatment of neurological diseases. Dr. Feldman has been continuously funded by the NIH since 1989 and is currently the principal or co-investigator of numerous clinical trials and grants. She has received numerous awards and honors throughout her remarkable career, including the University of Michigan’s Early Distinguished Career Award, the Distinguished Faculty Achievement Award, and the Distinguished Alumnus Achievement Award. She was also the first woman in 25 years to receive the Robert S. Schwab Award from the American Clinical Neurophysiology Society. In 2022, Dr. Feldman was awarded the University of Michigan Distinguished Professorship, the highest faculty honor at University of Michigan.Dr. Feldman is actively committed to and involved in professional service. She served as President of the Peripheral Nerve Society from 2007-2009 and President of the American Neurological Association (ANA) from 2011-2013. Dr. Feldman is an elected member of the National Academy of Medicine (NAM) and Association of American Physicians, and a Fellow of the American Association for the Advancement of Science. Dr. Feldman is the Editor of the Contemporary Neurology Series and also serves on a number of editorial boards for leading scientific journals, including The Lancet Neurology, Nature Reviews Neurology, JAMA Neurology and Journal of Neurology, Neurosurgery and Psychiatry. Dr. Feldman is rated as an Elite provider by MediFind in the treatment of Diabetic Neuropathy. She is also highly rated in 33 other conditions, according to our data. Her clinical expertise encompasses Peripheral Neuropathy, Diabetic Neuropathy, Amyotrophic Lateral Sclerosis (ALS or Lou Gehrig's Disease), and Autonomic Neuropathy. Dr. Feldman is board certified in Neurology and Electrodiagnostic Medicine.

Dr. Callaghan completed his medical degree and neurology residency at the University of Pennsylvania. He completed a fellowship in neuromuscular disease at the University of Michigan. He also completed a master's degree program in clinical research at the University of Michigan School of Public health. Dr. Callaghan is rated as an Elite provider by MediFind in the treatment of Diabetic Neuropathy. He is also highly rated in 9 other conditions, according to our data. His clinical expertise encompasses Peripheral Neuropathy, Diabetic Neuropathy, Amyotrophic Lateral Sclerosis (ALS or Lou Gehrig's Disease), Thrombectomy, and Thymectomy. Dr. Callaghan is board certified in Neurology.

Dr. Lynn Ang is currently a Clinical Associate Professor in the Metabolism, Endocrinology, and Diabetes Division, Internal Medicine Department at University of Michigan. Dr. Ang is one of the principle attending physicians for the Diabetes Transition Program. Dr. Ang’s clinical and research interests are in the fields of implementing optimal management of inpatient and outpatient hyperglycemia, creating protocols for inpatient hospital guidelines, identifying biomarkers to predict the development or progression of diabetic complications, detecting the earliest stages of complications to prevent progression of diseases, and developing sensitive diagnostic methods/treatment for those complications. Dr. Ang also serves as a Co-Director of Hospital Intensive Insulin Program. Dr. Ang has been actively involving in teaching internal medicine and podiatry residents, endocrinology fellows, and medical students in both ambulatory and inpatient clinical settings. She was a recipient of Goran Sundkvist Young Investigators Award for Clinical Science 2022. Dr. Ang is rated as a Distinguished provider by MediFind in the treatment of Diabetic Neuropathy. She is also highly rated in 6 other conditions, according to our data. Her clinical expertise encompasses Type 1 Diabetes (T1D), Diabetic Neuropathy, Type 2 Diabetes (T2D), and Maturity Onset Diabetes of the Young. Dr. Ang is board certified in Internal Medicine and Endocrinology, Diabetes & Metabolism.

Anuradha Puttagunta is an Endocrinologist practicing medicine in Ypsilanti, Michigan. Dr. Puttagunta is rated as an Advanced provider by MediFind in the treatment of Diabetic Neuropathy. She is also highly rated in 25 other conditions, according to our data. Her clinical expertise encompasses Type 1 Diabetes (T1D), Type 2 Diabetes (T2D), Thyroid Nodule, and Hypothyroidism.

Suma Amarnath is an Endocrinologist practicing medicine in Ypsilanti, Michigan. Dr. Amarnath is rated as an Advanced provider by MediFind in the treatment of Diabetic Neuropathy. She is also highly rated in 30 other conditions, according to our data. Her clinical expertise encompasses Type 1 Diabetes (T1D), Hyperthyroidism, Hypothyroidism, and Addison's Disease.

Anita Repp is an Endocrinologist practicing medicine in Ypsilanti, Michigan. Dr. Repp is rated as an Experienced provider by MediFind in the treatment of Diabetic Neuropathy. She is also highly rated in 34 other conditions, according to our data. Her clinical expertise encompasses Type 1 Diabetes (T1D), Osteoporosis, Postmenopausal Osteoporosis, and Type 2 Diabetes (T2D).

William H. Herman is the Stefan S. Fajans/GlaxoSmithKline Professor of Diabetes, Professor of Internal Medicine in the Division of Metabolism, Endocrinology, and Diabetes and Professor of Epidemiology in the School of Public Health. He completed his undergraduate degree at Yale University and received his medical degree from Boston University. He gained a Masters of Public Health (Epidemiology) from the University of Michigan. Professor Herman's interests include clinical diabetes and diabetes epidemiology, especially in the areas of surveillance, screening, treatment, cost-effective analysis, and health policy. He has authored more than 400 original research papers, reviews and textbook chapters and is U-M Principal Investigator for the Diabetes Control and Complications Trial (DCCT), Epidemiology of Diabetes Interventions and Complications (EDIC), Diabetes Prevention Program (DPP), Diabetes Prevention Program Outcomes Study (DPPOS), and The Glycemia Reduction Approaches in Diabetes: A Comparative Effectiveness Study (GRADE). Professor Herman received the American Diabetes Association's Kelly West Award for outstanding achievement in diabetes epidemiology in 2006 and the U-M Dean's Award for Clinical and Health Services Research in 2007. From 2018 to 2021, he chaired the National Clinical Care Commission, a federal advisory committee charged with advising the Congress how to leverage federal policies and programs to better prevent and control diabetes in the United States. He has been recognized by Best Doctors as a Best Doctor in America for more than 10 years. Dr. Herman is rated as an Advanced provider by MediFind in the treatment of Diabetic Neuropathy. He is also highly rated in 7 other conditions, according to our data. His clinical expertise encompasses Type 2 Diabetes (T2D), Maturity Onset Diabetes of the Young, Type 1 Diabetes (T1D), Diabetic Neuropathy, and Gastric Bypass. Dr. Herman is board certified in Internal Medicine and Endocrinology, Diabetes & Metabolism.

Nazanene H. Esfandiari, MD, is a Clinical Professor of Internal Medicine with an appointment in the Division of Metabolism, Endocrinology and Diabetes (MEND). Dr. Esfandiari received her medical degree from the University of Bordeaux in France, completed internal medicine residency in France and at UMASS Memorial Health Center in Massachusetts, and then completed fellowship in endocrinology at the University of Michigan. She joined the faculty at the University of Michigan in 2003. She was inducted into Clinical Excellence Society at the University of Michigan in 2014. She is the MEND Service Chief, Co-director of Hospital Intensive Insulin Program (HIIP) and Assistant Chief for the Inpatient Endocrine Consult.Dr. Esfandiari’s practice focuses on thyroid cancer, thyroid disorders, post bariatric care, and diabetes. She is also interested in medical education and is the Co-director of the Endocrine Sequence at the University of Michigan Medical School. In addition, Dr. Esfandiari has served in several national committees at the Endocrine Society and American Thyroid Association (ATA). Dr. Esfandiari is rated as an Advanced provider by MediFind in the treatment of Diabetic Neuropathy. She is also highly rated in 18 other conditions, according to our data. Her clinical expertise encompasses Thyroid Cancer, Follicular Thyroid Cancer, Anaplastic Thyroid Cancer, Gastric Bypass, and Thyroidectomy. Dr. Esfandiari is board certified in Endocrinology, Diabetes & Metabolism.

Dr. Kraftson specializes in treating patients with excess weight/obesity in addition to seeing patients with general endocrinologic conditions. He was inducted into the Clinical Excellence Society in 2021. He is the Director of the Weight Navigation Program & the Director of the Post Bariatric Endocrinology Clinic. Dr. Kraftson's research, focuses on gaining a better understanding of delivering effective care for individuals with obesity. In addition to these interests, Dr. Kraftson is actively involved in medical education and is the Associate Program Director for the M.E.N.D. Endocrinology Fellowship. Dr. Kraftson is rated as an Advanced provider by MediFind in the treatment of Diabetic Neuropathy. He is also highly rated in 24 other conditions, according to our data. His clinical expertise encompasses Obesity, Malnutrition, Type 2 Diabetes (T2D), Gastric Bypass, and Sleeve Gastrectomy. Dr. Kraftson is board certified in Endocrinology, Diabetes & Metabolism.

Dr. Wong earned her medical degree from the University of Michigan Medical School (2004) and completed her residency training with the Department (2007), where she also served as co-chief resident, and completed an academic fellowship (2008). Prior to joining the Department, she was in private practice at Packard Health in Ann Arbor, Mich. She sees patients at Ypsilanti Family Medicine. Dr. Wong is rated as an Experienced provider by MediFind in the treatment of Diabetic Neuropathy. Her clinical expertise encompasses Type 2 Diabetes (T2D), Maturity Onset Diabetes of the Young, Bowenoid Papulosis, Familial Hypertension, and Intrauterine Device Insertion.

Dr. Heidelbaugh received his medical degree from Upstate Medical University at Syracuse in 1996, and completed his Family Practice residency at St. Joseph's Hospital Health Center, also in Syracuse, New York, in 1999. He is board-certified by the American Board of Family Medicine. He is the Director for the Third Year Required Clerkship. Dr. Heidelbaugh is actively involved in teaching both medical students and residents at Ypsilanti Health Center, and attends on the Department of Family Medicine's inpatient adult medicine at the University of Michigan Hospital. His clinical interests include gastroesophageal reflux disease (GERD) and other disorders of the gastrointestinal system; preventive health screening for men, women and children of all ages; chronic disease management; men's health, dermatologic procedures, and prenatal care. Dr. Heidelbaugh's practice encompasses patients of all ages, with a wide spectrum of both medical and psychosocial disease states.Dr. Heidelbaugh has a joint appointment in Family Medicine and Urology. Dr. Heidelbaugh is rated as an Experienced provider by MediFind in the treatment of Diabetic Neuropathy. He is also highly rated in 12 other conditions, according to our data. His clinical expertise encompasses Irritable Bowel Syndrome (IBS), Maturity Onset Diabetes of the Young, Type 2 Diabetes (T2D), Hormone Replacement Therapy (HRT), and Endoscopy.

Sima Saberi is an Endocrinologist practicing medicine in Ann Arbor, Michigan. Dr. Saberi is rated as an Advanced provider by MediFind in the treatment of Diabetic Neuropathy. She is also highly rated in 20 other conditions, according to our data. Her clinical expertise encompasses Type 2 Diabetes (T2D), Diabetic Nephropathy, Type 1 Diabetes (T1D), Osteoporosis, and Thyroidectomy.

Dr. Bodnar is the Assistant Chief of Endocrinology & Metabolism at Ann Arbor VA Health System. He is a graduate of the University of Michigan Medical School, and completed Internal Medicine Residency and Chief Residency, as well as his Fellowship in Endocrinology at Michigan Medicine. From 2014-2021 he was in private practice at Ann Arbor Endocrinology & Diabetes and was a Key Clinical Faculty Member in the St. Joseph Mercy Ann Arbor Internal Medicine Residency. Dr. Bodnar is rated as an Experienced provider by MediFind in the treatment of Diabetic Neuropathy. He is also highly rated in 2 other conditions, according to our data. His clinical expertise encompasses Type 2 Diabetes (T2D), Type 1 Diabetes (T1D), Osteoporosis, and Pituitary Tumor. Dr. Bodnar is board certified in Internal Medicine and Endocrinology, Diabetes & Metabolism.

James Albers is a Neurologist practicing medicine in Ann Arbor, Michigan. Dr. Albers is rated as a Distinguished provider by MediFind in the treatment of Diabetic Neuropathy. He is also highly rated in 2 other conditions, according to our data. His clinical expertise encompasses Diabetic Neuropathy, Autonomic Neuropathy, Primary Lateral Sclerosis, and Sensorimotor Polyneuropathy.

Liselle Douyon is an Internal Medicine specialist and an Endocrinologist practicing medicine in Ann Arbor, Michigan. Dr. Douyon is rated as an Experienced provider by MediFind in the treatment of Diabetic Neuropathy. She is also highly rated in 37 other conditions, according to our data. Her clinical expertise encompasses Postmenopausal Osteoporosis, Osteoporosis, Thyroid Nodule, and Juvenile Primary Osteoporosis.

Amy E. Rothberg, MD, DABOM is Clinical Professor of Internal Medicine in the Division of Metabolism, Endocrinology and Diabetes (MEND) and Director of the MEND Weight Management Clinic, Research Professor of Nutritional Sciences and Director of Rewind, a virtual weight management and diabetes treatment program. She is an adjunct Professor in the School of Public Health at the University of Michigan.Dr. Rothberg served both her internship and residency in the Department of Internal Medicine at the University of Michigan Medical Center in Ann Arbor. She then completed the fellowship program in the Metabolism, Endocrinology & Diabetes at the University of Michigan Health System in Ann Arbor and then joined the faculty.Dr. Rothberg holds, or is a Co-Investigator, on research grants from the Michigan Nutrition Obesity Research Center, the Michigan Diabetes Research Center, and the National Institutes of Health. Dr. Rothberg is rated as an Experienced provider by MediFind in the treatment of Diabetic Neuropathy. She is also highly rated in 5 other conditions, according to our data. Her clinical expertise encompasses Obesity, Type 2 Diabetes (T2D), Obesity in Children, Familial Partial Lipodystrophy, and Gastric Bypass. Dr. Rothberg is board certified in Endocrinology, Diabetes & Metabolism.

Doctor Jennifer Wyckoff is a Clinical Professor of Internal Medicine in the Metabolism, Endocrinology and Diabetes/Podiatry Division. She received her MD degree from the University of South Florida in 1992 and completed her Internal Medicine Residency at the University of Utah in 1995. In addition, Dr. Wyckoff completed a fellowship in Endocrinology at the Brigham and Women's Hospital, Harvard Medical School, in 1999. Following that, she joined the faculty of the Joslin Diabetes Center, Harvard Medical School. While there, she practiced as part of the multidisciplinary Diabetes and Pregnancy program, a joint venture between the Joslin Diabetes Center and the Beth Israel Deaconess Hospital.In 2006, she joined the faculty at University of Michigan. Dr. Wyckoff serves as the Associate Clinical Chief for the Metabolism, Endocrinology and Diabetes/Podiatry Division and the Medical Director of the Adult Diabetes Education. Her clinical interests center on diabetes, with specific emphasis on diabetes and pregnancy, Type 1 diabetes and technology, patient education and cystic fibrosis related diabetes. Dr. Wyckoff is rated as an Experienced provider by MediFind in the treatment of Diabetic Neuropathy. She is also highly rated in 8 other conditions, according to our data. Her clinical expertise encompasses Type 1 Diabetes (T1D), Type 2 Diabetes (T2D), Secondary Immunodeficiency (SID), and Gestational Diabetes. Dr. Wyckoff is board certified in Internal Medicine and Endocrinology, Diabetes & Metabolism.

Jennifer Franzese is an Internal Medicine specialist and an Endocrinologist practicing medicine in Ann Arbor, Michigan. Dr. Franzese is rated as an Experienced provider by MediFind in the treatment of Diabetic Neuropathy. She is also highly rated in 9 other conditions, according to our data. Her clinical expertise encompasses Type 2 Diabetes (T2D), Type 1 Diabetes (T1D), Maturity Onset Diabetes of the Young, and Thyroid Nodule.

Dr. Elif Oral is a professor in the Division of Metabolism, Endocrinology and Diabetes (MEND) at the University of Michigan. She completed her medical education in her home country of Turkey at the University of Istanbul. In 1996, she completed her residency in Internal Medicine at Sinai Hospital Detroit (Michigan). She then completed a fellowship in Endocrinology, Metabolism and Diabetes at the National Institute of Health, where she also chose to stay as a Senior Fellow under the mentorship of Drs SimeonTaylor and Phillip Gorden in in the Diabetes Branch of NIDDK.Since joining the University of Michigan in 2002 as an Assistant Professor of Medicine, along with her regular faculty responsibilities, Dr. Oral also completed a Masters of Science Degree in Clinical Research Design and Biostatistics at the School of Public Health. Her clinical interests are in insulin resistance, obesity, lipid disorders, and diabetes.Dr Oral's research focuses on the importance of adipocytes in human metabolism and adipocyte hormones such as leptin. She is best known for her work showing the remarkable efficacy of leptin in rare lipodystrophy syndromes. Metreleptin received approval by the FDA (2014) and EMA (2016) as a treatment for lipodystrophy owing to a large part to her original vision and work. These studies provided the basis for her current work with three big goals: identification of novel metabolic diseases, discovery of new disease mechanisms and finding treatments for patients afflicted with these disorders. In addition to her roles as physician, educator, and researcher, Dr Oral is also the director of two programs at MEND: Atypical Diabetes Program and Obesity and Metabolic Disorders Program. She directed the Post-Bariatric Surgery Care Program from 2012 to 2021 and continues to conduct research on the cohort of patients who had bariatric surgery performed in the Michigan Bariatric Surgery program. Dr. Oral is rated as an Experienced provider by MediFind in the treatment of Diabetic Neuropathy. She is also highly rated in 16 other conditions, according to our data. Her clinical expertise encompasses Familial Partial Lipodystrophy, Congenital Generalized Lipodystrophy, Familial Hypertriglyceridemia, Gastric Bypass, and Sleeve Gastrectomy. Dr. Oral is board certified in Endocrinology, Diabetes & Metabolism.

Cristina Nieves is an Internal Medicine specialist and an Endocrinologist practicing medicine in Ann Arbor, Michigan. Dr. Nieves is rated as an Experienced provider by MediFind in the treatment of Diabetic Neuropathy. She is also highly rated in 24 other conditions, according to our data. Her clinical expertise encompasses Toxic Nodular Goiter, Thyroid Storm, Type 2 Diabetes (T2D), and Low Blood Sugar. Dr. Nieves is board certified in Internal Medicine and Endocrinology, Diabetes & Metabolism.